 | Circadian owns 100 percent of Vegenics Limited, a major cancer therapies commercial partnership originally initiated in collaboration with the Ludwig Institute for Cancer Research (LICR) and Licentia Limited, the commercial arm of the University of Helsinki.
|
| |